Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideALNYAlnylam Pharmaceuticals
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | ALNY | TMO |
|---|
| Close | 227.02 | 662.24 |
| Market Cap | $31.1B | $243B |
| 1M | −8.71% | +8.60% |
| P/E (TTM) | 38.5 | 34.9 |
| Forward P/E | 28.0 | 24.6 |
| P/E 5-Yr Percentile | — | 66 |
| P/S | 6.5 | 5.3 |
| P/B | 23.0 | 4.6 |
| Dividend Yield | — | 0.29% |
| Latest Quarter Revenue | $1.3B | $12.0B |
| Revenue YoY | +66.9% | +10.5% |
| Gross Margin | 76.9% | — |
| Latest Quarter EPS | 1.21 | 4.68 |
| Avg Post-Earnings Move | ±1.7% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | — | 2.33% |
| 90-Day Net Insider Buying | −$0.40M | −$38.9M |
ALNY · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
